They all sign non disclosures, I don't know rules in terms of public companies but someone posted awhile ago a filing that detailed the history of a deal and prices were discussed a year plus before any deal and any announcement so I would guess unless there is pen to paper on a deal they don't need to announce anything. Makes sense, would open up a huge avenue of stock manipulation.
It could be that BB and the board had preliminary discussions and feel based on what was discussed with BP and what path they want to take that selling the company is the preferred route. They will know more after FDA approval is my guess. If they are wrong and BP tries to screw them with low ball offers after approval they go ahead and hire and call the bluff.
If they believe they are going to sell why hire people, train them, have all that expense and then let them all go a couple months later? If you have to GIA, even for a short time after FDA approval because offers do not materialize as you thought you lose basically 60-90 days of time on added sales staff, probably worth the cost/reward.
On another note, other than hiring, there is not much they can do until approval of expanding label, They can still prepare a marketing blitz but we would not know because they can't release it until after approval. It's really partnering and sales hiring that could be done now if they think GIA is the likely path, and they could still do that later this month if that is the path they choose.
Deals fall apart at last minute all the time. You have to weigh risk/reward and think JT has a strong team guiding him.
News 
Market Data 
Discover 
